ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer (XCITE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01767857
Recruitment Status : Terminated (The study crossed the prospective futility boundary of primary endpoint)
First Posted : January 14, 2013
Last Update Posted : August 29, 2017
Sponsor:
Information provided by (Responsible Party):
XBiotech, Inc.